Skip to main content
Binex Co., Ltd. logo

Binex Co., Ltd. — Investor Relations & Filings

Ticker · 053030 ISIN · KR7053030003 KO Manufacturing
Open in API
Filings indexed 223 across all filing types
Latest filing 2023-03-02 Proxy Solicitation & In…
Country KR South Korea
Listing KO 053030

About Binex Co., Ltd.

http://www.binex.co.kr/

Binex Co., Ltd. is a biopharmaceutical company engaged in two main sectors: synthetic pharmaceuticals and biologics contract services. The pharmaceutical division manufactures and distributes a portfolio of products, including gastrointestinal tract regulators, antispasmodics, and anti-cancer drugs. As a Contract Development and Manufacturing Organization (CDMO), the company provides comprehensive services for biologics, specializing in cell line development, process development, and analytical method development. Its quality management systems are recognized by major international regulatory authorities such as the FDA, EMA, and PMDA, establishing it as a key partner in biopharmaceutical development and manufacturing.

Recent filings

Filing Released Lang Actions
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in Korea (Proxy Solicitation & Information Statement). It contains details regarding the upcoming Annual General Meeting (AGM), including the date, agenda items (approval of financial statements, appointment of directors, etc.), and instructions for shareholders to exercise their voting rights via proxy, electronic voting, or mail. While it includes financial statements, these are provided as supporting information for the AGM agenda, not as a standalone Annual Report or Audit Report.
2023-03-02 Korean
교환사채(해외교환사채포함)발행후만기전사채취득
Capital/Financing Update Classification · 100% confidence The document is a regulatory filing from a Korean company (Binex) detailing the acquisition of its own exchangeable bonds before maturity. This falls under capital structure changes and financing updates. Since it specifically details the repurchase/acquisition of debt instruments (bonds) by the issuer, it aligns best with the 'Capital/Financing Update' category.
2023-01-06 Korean
전환사채(해외전환사채포함)발행후만기전사채취득
Capital/Financing Update Classification · 100% confidence The document is a regulatory filing from the Korean Exchange (KRX) regarding the acquisition of convertible bonds before maturity. It details the specific bond series, the amount acquired, the reason (early redemption request by the bondholder), and the method of acquisition. This falls under capital structure changes and financing updates, specifically related to debt instruments, which is best categorized as CAP (Capital/Financing Update).
2023-01-06 Korean
[기재정정]신규시설투자등
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from a Korean company (Binex) regarding a 'Correction Report' (정정신고) for a 'New Facility Investment' (신규시설투자). It details changes to the investment period end date and provides specific financial data regarding capital expenditure. Since this is a formal regulatory announcement regarding corporate capital investment and its amendment, it falls under the 'Regulatory Filings' category as it does not fit into specific categories like M&A or Share Issues.
2022-12-23 Korean
[기재정정]생산중단
Legal Proceedings Report Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) system, specifically a 'Correction Report' (정정신고) regarding a previous 'Production Suspension' (생산중단) announcement. It details changes to the suspension period due to legal proceedings and administrative actions. Since it is a formal regulatory disclosure of a material business event (production suspension) and does not fit into specific categories like financial reports or shareholder meetings, it is classified as a Regulatory Filing (RNS).
2022-12-23 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date and shareholder register closure for an upcoming Annual General Meeting (AGM). It does not contain the full AGM materials or proxy statements, but rather serves as a formal notice of the procedural steps required for the meeting. Given its nature as a regulatory notification of a corporate event, it fits best under the RNS category.
2022-12-13 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.